Literature DB >> 8738972

Immune regulation in type 1 diabetes.

A Shimada1, B Charlton, P Rohane, C Taylor-Edwards, C G Fathman.   

Abstract

The non-obese diabetic (NOD) mouse is an animal model of insulin-dependent diabetes mellitus (IDDM) that shows many of the characteristics of human IDDM. In the NOD model, there exists a discrepancy between the onset of insulitis and diabetes suggesting the potential existence of some form of immune regulation that delays beta cell destruction. Our transfer system using NOD-scid/scid (NOD-scid) mice as recipients of donor NOD cells suggested that immune regulatory cells exist in the periphery of NOD mice, not in the islets. These regulatory cells are considered to be memory CD4+ cells which show a Th2 (or Th zero) type cytokine profile following activation in vitro. The function of the memory CD4+ cells seems to change from protective to pathogenic as the disease progresses. Moreover, cytokine profiles of this CD4+ CD45RBlow (memory) population shifted from a Th2 (or Th zero) to a Th1 type response coincident with the onset of hyperglycaemia. These data suggest that the progression of NOD disease from insulitis to frank hyperglycaemia is under the control of CD4+ CD45RBlow immune 'regulatory' cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738972     DOI: 10.1006/jaut.1996.0033

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  11 in total

Review 1.  Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease.

Authors:  S T Azar; H Tamim; H N Beyhum; M Z Habbal; W Y Almawi
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

Review 2.  Allergy and dermatophytes.

Authors:  Judith A Woodfolk
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Identification of a novel type 1 diabetes susceptibility gene, T-bet.

Authors:  Yuka Sasaki; Kenji Ihara; Nobuo Matsuura; Hitoshi Kohno; Seiho Nagafuchi; Ryuichi Kuromaru; Koichi Kusuhara; Ryu Takeya; Timothy Hoey; Hideki Sumimoto; Toshiro Hara
Journal:  Hum Genet       Date:  2004-07-06       Impact factor: 4.132

Review 4.  CXCL10 activities, biological structure, and source along with its significant role played in pathophysiology of type I diabetes mellitus.

Authors:  Zahra Ahmadi; Mohammad Kazemi Arababadi; Gholamhossin Hassanshahi
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

Review 5.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

6.  The role of the CXCL10/CXCR3 system in type 1 diabetes.

Authors:  Akira Shimada; Yoichi Oikawa; Yoshifumi Yamada; Yoshiaki Okubo; Shosaku Narumi
Journal:  Rev Diabet Stud       Date:  2009-08-10

7.  T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice.

Authors:  S V Pakala; M O Kurrer; J D Katz
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

8.  Self-glycolipids modulate dendritic cells changing the cytokine profiles of committed autoreactive T cells.

Authors:  Karsten Buschard; Jan-Eric Månsson; Bart O Roep; Tatjana Nikolic
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

9.  CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.

Authors:  A M Thornton; E M Shevach
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

10.  Th1/Th2 cytokines in Type 1 diabetes: Relation to duration of disease and gender.

Authors:  Hajar Vaseghi; Zohreh Jadali
Journal:  Indian J Endocrinol Metab       Date:  2016 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.